Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Two American scientists receive Paul Ehrlich and Ludwig Darmstaedter Prize

Two American scientists receive Paul Ehrlich and Ludwig Darmstaedter Prize

Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

Unregulated Internet marketing of cancer-related gene tests poses challenges for consumers, physicians

Unregulated Internet marketing of cancer-related gene tests poses challenges for consumers, physicians

Targeting stroma could potentially extend survival of pancreatic cancer patients

Targeting stroma could potentially extend survival of pancreatic cancer patients

Researchers report that 15% of pancreatic cancer patients may benefit from personalized therapies

Researchers report that 15% of pancreatic cancer patients may benefit from personalized therapies

Mayo Clinic researchers identify molecule that lays groundwork for development of pancreatic cancer

Mayo Clinic researchers identify molecule that lays groundwork for development of pancreatic cancer

CTCA presents research on new cancer nutrition therapies at A.S.P.E.N. Clinical Nutrition Week

CTCA presents research on new cancer nutrition therapies at A.S.P.E.N. Clinical Nutrition Week

Researchers identify molecule that plays key role in aggressive thyroid cancer, other cancers

Researchers identify molecule that plays key role in aggressive thyroid cancer, other cancers

Oncolytics Biotech’s REOLYSIN receives Orphan Drug Designation for treatment of pancreatic cancer

Oncolytics Biotech’s REOLYSIN receives Orphan Drug Designation for treatment of pancreatic cancer

Combination therapies may overcome resistance to targeted cancer drugs

Combination therapies may overcome resistance to targeted cancer drugs

41% of the British population unaware of the role of diet in cancer development

41% of the British population unaware of the role of diet in cancer development

Chinese researchers achieve major breakthrough in nano-carrier drugs for pancreatic cancer

Chinese researchers achieve major breakthrough in nano-carrier drugs for pancreatic cancer

Researchers devise new technique to deliver cancer treatment

Researchers devise new technique to deliver cancer treatment

Research findings demonstrate new approach to transform behavior of tumor cells

Research findings demonstrate new approach to transform behavior of tumor cells

Researchers are one step closer to devising an approach to identify pancreatic cancer earlier

Researchers are one step closer to devising an approach to identify pancreatic cancer earlier

Pancreatic Cancer Action Network praises President Obama for new Precision Medicine Initiative

Pancreatic Cancer Action Network praises President Obama for new Precision Medicine Initiative

Pancreatic cancer cells know a way to sidestep chemotherapy, reveal Fox Chase researchers

Pancreatic cancer cells know a way to sidestep chemotherapy, reveal Fox Chase researchers

Researchers use game theory to predict interactions of cancer cells

Researchers use game theory to predict interactions of cancer cells

HCI researchers find cell mechanism that may trigger pancreatic cancer

HCI researchers find cell mechanism that may trigger pancreatic cancer

Dr. Hans Clevers receives ISSCR's McEwen Award for Innovation

Dr. Hans Clevers receives ISSCR's McEwen Award for Innovation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.